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Abstract
Background: In recent years, it has been increasingly recognized that the absence of mental disorder is not the
same as the presence of positive mental health (PMH). With the PMH-scale we propose a short, unidimensional
scale for the assessment of positive mental health. The scale consists of 9 Likert-type items.
Methods: The psychometric properties of the PMH-scale were tested in a series of six studies using samples from
student (n = 5406), patient (n = 1547) and general (n = 3204) populations. Factorial structure and measurement
equivalence were tested with the measurement invariance testing. The factor models were analysed with the
maximum likelihood procedure. Internal consistency was examined using Cronbach’s alpha, test-retest reliability,
convergent and divergent validity was examined by Pearson correlation. Sensitivity to (therapeutic) change was
examined with the t-test.
Results: Results confirmed unidimensionality, scalar invariance across samples and over time, high internal
consistency, good retest-reliability, good convergent and discriminant validity as well as sensitivity to
therapeutic change.
Conclusions: These findings suggest that the PMH-Scale indeed measures a single concept and allows us to
compare scores over groups and over time. The PMH-scale thus is a brief and easy to interpret instrument for
measuring PMH across a large variety of relevant groups.
Background
Mental health has traditionally been defined as the
absence of psychopathology [30]: Individuals were seen
as either mentally ill or presumed to be mentally healthy.
In recent years, however, it is increasingly recognized
that the absence of mental disorder is not the same as
the presence of positive mental health [62]. Thus, ele-
ments of positive mental health (PMH) and mental
health problems can be present at the same time: They
are seen as independent but correlated concepts (e.g.,
[31, 36, 52]). In this view, both positive mental health
(PMH, often also referred to as mental well-being) and
mental disorder (often referred to as mental health prob-
lems, psychopathology or negative well-being) are re-
quired for complete mental health assessments and
should be integrated in research (“dual-factor model of
mental health”, e.g., [52])1.
Two theories dominate the field regarding the compo-
nents of PMH [9, 45]: The hedonic tradition deals with
positive affect (or positive emotions and moods) and
high life-satisfaction, whereas the eudaimonic tradition
focuses on optimal functioning of an individual in every-
day life [29, 30, 60]. Taking both the hedonic and the
eudaimonic approaches into account, PMH can be
defined as the presence of general emotional, psycho-
logical, and social well-being [32]. While individual
characteristics of PMH can be measured with specific
instruments (e.g., [14, 50, 53]), comprehensive question-
naires assess multiple dimensions of PMH (e.g., Mental
Health Continuum-Short Form MHC-SF; [33]) or in-
clude items relating to both PMH and psychopathology
(e.g., General Health Questionnaire GHQ; [22]). The
Positive Mental Health Scale (PMH-scale; Lutz et al.
1992a, unpublished manuscript) was developed to meas-
ure positive mental health with a brief, unidimensional
and person-centred questionnaire. Unidimensionality
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[51] ensures that the scale measures a single concept as
postulated by the holistic concept of PMH. Person-
centred items have the advantage that statements consist
of cross-situationally stable judgments about the par-
ticipant rather than predictions about specific behav-
iours in particular situations (“I am…”, e.g., Freiburg
Personality Inventory FPI; [12]).
Several criteria for the formulation and content of the
items were used for the initial selection of the items for
the PMH-scale: The items had to correspond with the
definition of PMH being general, cross-situational and
person-centred. The person-centred items focus on the
consistency of a person’s overall characteristic pattern
across many situations, while the behaviour-centred
items instead focus on the behaviour pattern in specific
situations [15]. In addition, the PMH-scale was con-
structed to measure the inner factors (e.g. emotional and
psychological) of positive mental health in suppose to
the outer factors (e.g. social support, partnership). The
scale was to require having an unidimensional, self-
reporting, brief, easy to complete and sensitive to
change. For the development of the PMH-scale, Lutz et
al. (1992a, unpublished manuscript) used items from
their own item pool and from the pool of four German
language instruments that met these selection criteria
(Trier Personality Inventory, [5]; Freiburg Personality
Inventory, [12]; Mental Health Scale, [53]; Bernese
questionnaire of subjective well-being, [17]). The final
version that Lutz et al. (1992a, unpublished manuscript)
produced was reduced to nine items (see Table 1) that
are rated on a Likert scale from 1 (not true) to 4 (true).
Earlier version of the PMH-scale was found to be
among the most important predictors of remission from
specific [54] or social phobia [59] in the Dresden
Predictor Study of Mental Health [55]. Analyses of a
broad range of predictors of remission from specific
phobia [54] of 137 participants revealed that protective
factors, particularly positive mental health and life
satisfaction at baseline, were predictive of remission.
Other protective (social support and self-efficacy),
vulnerability factors (twelve-month stress, coping skills,
negative cognitive style and psychopathology) and specific
phobia characteristics (severity and age of onset) at
baseline did not predict course of specific phobia. Recov-
ery from social phobia [59] of 91 participants was signifi-
cantly predicted by less psychopathology, less anxiety
sensitivity, less number and less stress of daily hassles and
better positive mental health. In a multivariate regression
model, after adjustment of the other salient predictors of
recovery, positive mental health showed to be the stron-
gest predictor of recovery from social phobia. These re-
sults support health promotion programs focused on
salutogenetic factors and not only prevention concerning
traditional pathogenetic factors and mental disorders.
In addition, the PMH-scale and the wish to receive pen-
sion were found (Lutz and Michalak 2001, unpublished
manuscript) to predict the success of behaviour therapy
with inpatients.
These results encouraged us to investigate the psycho-
metric properties and usefulness of the current nine-
item version of the PMH-scale in greater detail. For this
purpose we conducted a series of five studies building
on samples drawn from patients (n = 1547), students
(n = 5406) and the general population with and with-
out mental disorders (n = 3204). This study had the
following objectives (Fig. 1):
– To examine whether the nine items of the
PMH-scale load on a single factor and to
examine the equivalence of the PMH-scale for
different populations (study 1).
– To examine whether the PMH-scale is invariant
over time (study 2); a requirement for usage in
intervention studies.
– To estimate the test-retest reliability, internal
consistency and correlation across time of the
scale (study 3).
– To establish the construct validity of the scale
by assessing its convergent and discriminant
validity (study 4).
Table 1 The items of the PMH-scale and their origin
Item Origin of the item
1. I am often carefree and in good spirits. Trierer Personality Inventory (TPF)
2. I enjoy my life. Item from Lutz’s item pool
3. All in all, I am satisfied with my life. Freiburg Personality Inventory (FPI-R)
4. In general, I am confident. Mental health scale (SPG)
5. I manage well to fulfill my needs. Trier Personality Inventory (TPF)
6. I am in good physical and emotional condition. Trier Personality Inventory (TPF)
7. I feel that I am actually well equipped to deal with life and its difficulties. Trier Personality Inventory (TPF)
8. Much of what I do brings me joy. Mental Health Scale (SPG)
9. I am a calm, balanced human being. Trier Personality Inventory (TPF)
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– To evaluate the scale’s sensitivity to therapeutic
change (study 5).
Methods
Samples and procedures
Table 2 shows the socio-demographic data for all sam-
ples. Participants in all samples had given informed con-
sent based on information about the individual studies
and the assurance of anonymity. The studies form part
of the larger Bochum Optimism and Mental Health
study program (BOOM). The ethics committee approval
was different for the samples. The ethical approval for
the student sample and the retest samples was ob-
tained by the Ethics Committee of the Faculty of
Psychology at Ruhr-University Bochum. The study
with the patient sample received ethical approval from
the German Federal Insurance Institution for Em-
ployees (Bundesversicherungsanstalt für Angestellte;
BfA). The study with the Dresden sample received
ethical approval from the Office for Data Protection
(in Saxony, Amt für Datenschutz, Staat Sachsen) and
the State of Saxony Public Health Association.
Student sample
In the fall of 2011, all 31.994 students of Ruhr-
University Bochum received an e-mail inviting them
to participate in a survey on mental health. Based
on information about the study and an assurance of
anonymity, a total of 5406 students (16.9 %) gave
informed consent and participated in the survey that
consisted of a demographic questionnaire, the PMH-
scale, self-report instruments (some of which are
used to validate the PMH-scale, e.g. SWLS; EQ-5D;
SHS; DASS stress, anxiety, depression; SOZU-K) and
five additional questionnaires that are not analysed
in this study.
Fig. 1 An overview over the five studies – objectives and samples
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Retest sample 1
Participants were recruited in March and April 2012
among employees of three different facilities (St.Elisabeth
Hospital Hattingen, Lebenshilfe Kleve, Tagesklinik
Warstein) and inhabitants of the city of Kleve (Germany).
Via a snowball sampling procedure we invited ac-
quaintances, current and former colleagues per e-mail
or a letter, to participate in the study. Based on infor-
mation about the study and an assurance of anonym-
ity, 167 participants, neither seeking mental health
care nor receiving psychological treatment gave in-
formed consent and completed a battery of question-
naires consisting of a demographic questionnaire, the
PMH-scale and three other self-report instruments
used to validate the PMH-scale (CES-D; SOC; N-
scale). After an average of 7.4 days, 138 participants
(83 %) completed the PMH-scale a second time.
There were no significant differences between com-
pleters and dropouts at baseline. To minimize the
administrative burden, the SOC and the CES-D were
included in the baseline survey and the N-scale was
included in the follow-up.
Retest samples 2 and 3
In summer and fall 2013, two samples representative for
the German adult population (age 18 and above) were
recruited via telephone. Participants completed the
PMH-scale online or by mail twice with a time lag of
either one week (retest sample 2, n = 1004) or four
weeks (retest sample 3, n = 1294).
Patient sample
Between January 1998 and August 2000 data was
collected on 1547 patients who received cognitive-
behavioral therapy in the psychosomatic hospital “Edertal”
in Bad Wildungen (Germany). After giving informed
consent patients completed a battery of questionnaires
within one to six days after their admission at the clinic.
The average treatment time was six weeks. One to five
days before discharge, 80 % (n = 1232) of the patients who
had participated at the baseline completed the question-
naires for the second time. The diagnoses of the patients
were based on the standard diagnostic criteria according
to the ICD-9 definitions [61]. At baseline, 25.3 % (n = 391)
of the 1547 patients were missing data on the main
Table 2 Socio-demographic data for the seven samples (percentage of the respective samples)
Characteristics Students Retest samples Patients Dresden Predictor Study samples
Retest
sample 1
Retest
sample 2
Retest
sample 3
Stable
healthy
Incidence Stable
mentally ill
Remission
Sample size 5406 167 1004 1294 1547 683 169 232 310
Age (years): mean (S.D.) 26.3 (4.0) 36.7 (12.9) 43.4 (13.0) 54.7 (17.1) 48.9 (8.4) 22.7 (1.8) 22.6 (1.8) 22.7 (1.8) 22.7 (1.8)
Gender (%)
Female 55.5 68.9 49.9 43.9 74.8 100 100 100 100
Male 44.5 31.1 50.1 56.1 25.2 - - - -
Marital status (%)
Single 30.3 12.6 34.6 21.6 8.3 35.0 40.2 37.1 35.2
Partnership 40.0 36.5 2.1 1.1 7.9 60.6 56.8 57.8 59.7
Married 0.3 43.7 51.7 57.0 62.8 4.2 3.0 5.2 4.8
Divorced 0.3 6 9.9 9.1 15.7 0 0 0 0
Widowed 0 1.2 1.7 11.2 5.3 0.1 0 0 0.3
Occupation (%)
Self-employed - 6.7 - - 2.7 0.3 1.4 1.1 1.4
Manual worker/technician - 8.6 - - 9.3 12.5 13.7 16.0 13.7
Simple/mid-level employee - 66.9 - - 61.5 51.4 47.9 54.3 68.3
White-collar/executive employee - 4.3 - - 13.6 4.2 2.7 4.3 5.8
Other (students, pensioner etc.) 100 13.5 20.5 39.4 12.7 31.6 34.2 24.5 24.5
Employment (%)
Full time - 66.5 47.7 32.0 45.3 29.6 26.6 27.6 28.7
Part time - 25.1 18.4 17.25 21.3 17.7 15.4 15.5 19.0
Non-working - 8.4 6.8 8.0 15.9 50.4 54.4 49.1 46.8
Unemployed - 0 6.5 3.3 17.5 2.4 3.6 7.8 5.5
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diagnosis. Out of the 1156 patients with a main diagnosis
60.3 % had neurotic disorders, 17.4 % a functional
disorder of psychological origin, 17 % an adjustment
disorder, 1.6 % an affective psychosis, and 3.7 % another
diagnosis. A total of 56.4 % of the patients had at least one
comorbid diagnosis.
Dresden sample
This sample consisted of 1394 young German women
who participated in the Dresden Predictor Study (DPS;
[55]), a prospective epidemiological study of mental
disorders. In the DPS, young women aged 18–25 years
were randomly selected from the 1996 population regis-
ters of residents of Dresden (Germany). A baseline survey
was conducted from July 1996 to September 1997 and a
follow-up assessment 17 months later (M = 16.9 months,
SD = 6.0, range = 7–30 months). At both times, structured
clinical interviews for DSM-IV diagnoses were conducted
with each participant (F-DIPS; translation: Research Diag-
nostic Interview for Psychological Disorders, [39]; this is
the German version of the Anxiety Disorder Interview
Schedule-Lifetime, ADIS-IV-L; DiNardo et al. 1995). The
anxiety disorders included generalized anxiety disorder,
panic disorder with and without agoraphobia, agoraphobia
without history of panic disorder, specific phobia, social
phobia, obsessive-compulsive disorder, posttraumatic
stress disorder and acute stress disorder. The affective
disorders included dysthymic disorder, major depressive
disorder (single episode, recurrent), bipolar I and II
disorder and cyclothymic disorder. The somatoform
disorders included somatization disorder, undifferenti-
ated somatoform disorder, conversion disorder, pain
disorder and hypochondriasis. The substance disor-
ders included alcohol, medicine and drug abuse and
dependency. The eating disorders included anorexia
nervosa and bulimia nervosa. The current study is
restricted to those participants who completed the
diagnostic interview as well as a battery of self-report
questionnaires including the PMH-scale at both times
of data collection. For the determination of sensitivity
to change of the PMH-scale we divided the Dresden
sample into four subgroups based on the absence or
presence of mental disorders at the two assessment
times as follows:
Stable healthy
Participants (n = 683) who had no history of a mental
disorder and who had no mental disorder at any time.
Incidence
Participants (n = 166) who did not suffer from any
disorder prior to the baseline or at the baseline, but
who developed one or more mental disorders during
the 17-month follow-up period. At follow-up, 75.1 %
of these women suffered from anxiety disorder, 27.8 %
from affective disorder, 5.9 % from somatoform disorder,
3.6 % from substance abuse and/or dependence and 2.4 %
from eating disorder.
Stable mentally ill
Participants (n = 232) who met DSM-IV criteria for a
lifetime prevalence of one or more mental disorders at
the first assessment and who also suffered from a mental
disorder at the second assessment (baseline/follow-up
diagnoses: Anxiety disorder: 79.7 % / 81.5 %, affective dis-
order: 32.8 % / 27.6 %, somatoform disorder: 6.9 % / 8.2 %,
substance abuse and/or dependence: 16.9 % / 8.2 %,
eating disorder: 8.6 % / 7.3 %, childhood mental
disorders: 21.6 % / 0 %).
Remission
Participants (n = 310) who met criteria for at least one
mental disorder only in the past and/or at baseline, but
not at the follow-up. At the initial assessment 59.7 % of
these women had an anxiety disorder, 31.6 % an
affective disorder, 6.8 % a somatoform disorder, 1.9 % a
substance abuse and/or dependence, 9.7 % an eating
disorder and 24.5 % a lifetime prevalence of childhood
mental disorders.
Instruments
All studies employed the PMH-scale. In addition, the
following instruments were used in study 4 to determine
convergent and discriminant validity2:
 Social Support Scale (SOZU-K; [16]). Higher scores
indicate greater levels of social support.
 Satisfaction With Life Scale (SWLS; [11]). High
scores denote high levels of satisfaction.
 EuroQol Health Questionnaire (EQ-5D; [42]). Low
scores point to good subjective health.
 Subjective Happiness Scale (SHS; [37]). Higher
scores essentially reflect higher levels of
subjective happiness.
 Depression Anxiety Stress Scales-21 (DASS-21;
[34]). Higher scores mark greater levels of distress
(stress, anxiety, and depression).
 Neuroticism (N-scale, a modified version of the
12-item emotionality scale of the revised Freiburg
Personality Inventory, FPI-R; [12]). Participants
scored the items on a scale from 1 (not true) to
4 (true) in the modified version instead of a
2-point rating scale. High scores on the N-scale
indicate high neuroticism.
 Sense of Coherence Scale (SOC; [35]). High scores
on the SOC point to a high sense of coherence.
 Center for Epidemiological Studies Depression Scale
(CES-D; German version; [43]; German: Allgemeine
Lukat et al. BMC Psychology  (2016) 4:8 Page 5 of 14
Depressionsskala Kurzform, ADS-K; [18]). Higher
scores indicate pronounced levels of depressive
symptoms.
 General Self-efficacy Scale (GKE; [27]). Higher
scores denote more self-efficacy.
 Life Satisfaction Questionnaire (LZH; Lutz et al.
1992b, unpublished manuscript). Lower scores
indicate higher life satisfaction.
 Beck Depression Inventory (BDI; [4]). High scores
signify more severe depression.
In study 5 (sensitivity to therapeutic change) the
following instrument was used in addition to the
PMH-scale:
 Global Assessment of Functioning (GAF; [2]).
This numeric 0-100 scale is used by mental health
clinicians to rate the social, occupational, and
psychological functioning of adults. High scores
represent a high level of functioning.
Statistical analyses
The PMH-scale is a general scale designed to meas-
ure PMH in a variety of groups on single occasions
and across time. Therefore, it is required that the
PMH-scale is equivalent for groups and across time.
Measurement equivalence is tested with a procedure
called measurement invariance testing [41]. Three
forms of measurement invariance are important for
the goals that we intend to use our PMH-scale for:
(1) configural, (2) metric, and (3) scalar invariance.
The test for configural invariance determines whether
the factor structure is the same over groups and/or
across time. In the test for metric invariance we
determine whether the scale of the latent factor
(PMH-scale) has the same metric over groups and/or
across time. This is tested by imposing equality con-
straints on factor loadings. The scalar invariance test
establishes whether the scale of the latent factor
(PMH-scale) has the same zero point over groups
and/or across time. This is tested by imposing equal-
ity constraints on the item intercepts.
It is important for a scale to have these invariance
properties, because they have consequences for the
interpretation of the analyses with this scale, such as
comparing groups. When a scale is configural invari-
ant, the same construct is measured over groups and/
or across time. In case a scale is metric invariant, it
is valid to compare relations with other variables over
groups and/or across time. If a scale is scalar invari-
ant, means over groups and/or across time can be
compared. This is particularly important when the
scores of the PMH-scale are to be compared between
groups and/or across time.
We analysed the factor models with LISREL 8.8 [28]
using the maximum likelihood procedure. This procedure
was applied to the data even though the variables were not
normally distributed (skewness ranged between -1.6 and
1.0 and the kurtosis ranged between -1.0 and 2.4). However,
robustness studies by Anderson and Amemiya [1], Satorra
and Bentler [49], and Satorra [48] have shown that the so-
called “quasi maximum likelihood” estimator, which is LIS-
REL’s implementation of ML, is robust under quite general
conditions.
Current practice to evaluate model fit is to use fit indices,
especially the RMSEA. Recent studies, however, have
shown that fit indices with fixed critical values (e.g., the
RMSEA, GFI) do not work as intended because it is not
possible to control for type I and type II errors [3, 40, 47].
In this study, the number of observations is very high,
resulting in very high power to detect even the smallest
misspecification. As a result our model will be rejected,
even though it is adequate for all practical purposes. An al-
ternative procedure to evaluate models was developed by
Saris et al. [47]. They suggest searching for misspecifica-
tions in the model. Hu and Bentler [21] state that a model
is misspecified when (a) one or more parameters are esti-
mated while their population values are zero, (b) one or
more parameters are fixed to zero while their population
values are not zero, and (c) both. Saris et al. consider the
second type of misspecification the most serious. In their
procedure they combine the modification indices (indicat-
ing the second type of misspecifications discussed above)
with the power of the test to detect misspecifications. This
procedure is implemented in the software package JRule
(Van der Veld et al. [57]). For the current multigroup factor
analyses we used the JRule settings as described in Van der
Veld and Saris [56]. Model evaluation in this procedure en-
tails testing for misspecified parameters. If misspecified pa-
rameters are found, they are either estimated in the model
or their equality constraints are removed. Despite the fact
that one single misspecification may invalidate the inter-
pretation of the model, we do accept that models may have
several misspecifications. This is in line with Browne and
Cudeck [7] and MacCallum et al. [38] who suggested that
models are always simplifications of reality and are there-
fore always misspecified. Therefore, we were rather sparse
with model modifications. We do aim for a factor model
that represents a scale that is adequate for all practical pur-
poses. That means that we ignore a (misspecified) param-
eter if estimation of that parameter hardly changes the
interpretation of the model. In our factor analyses we have
operationalized hardly as when factor loadings change less
than approximately .07 after the introduction of a (misspe-
cified) parameter. In addition to this new model evaluation
procedure we do also provide the RMSEA, the NNFI, and
the χ2 test statistic for the reader who is interested in those
figures.
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Finally, the search for misspecifications was focused
on different parameters in the tests for configural,
metric, and scalar invariance. In the test for configural
invariance, the model is constrained on the correlated
errors; they are zero across the groups. Therefore we
focused on misspecifications on that part - correlated
errors - of the model. In the test for metric invariance
the factor loadings are constrained; for each item they
are the same across the groups. Therefore we focused on
misspecifications on that part - factor loadings - of the
model. In the test for scalar invariance the intercepts are
constrained; for each items the intercepts are the same.
Therefore we focused on misspecifications on that part -
item intercepts - of the model. The word focus is used
in the above sentences to mean more or less exclusively
focus. Thus, misspecifications solved in the configural
invariance test are first correlated errors, misspecifica-
tions solved in the metric invariance test are first factor
loadings, and misspecifications solved in the scalar
invariance test are first item intercepts. All other statis-
tical analyses were conducted using IBM SPSS Statistics
Version 21.0 [23].
Results
Descriptive statistics
Means (M), standard deviations (SD), skewness, and kur-
tosis were calculated for each of the nine PMH- scale
items of the three largest samples (Table 3). The means
of the 4-point Likert items ranged in the patient sample
from 1.62 (Item 7) to 2.78 (Item 4), with average M of
2.36 and a SD of 0.33. The means ranged in the student
sample from 2.81 (Item 5) to 3.19 (Item 4), with average
M of 3.01 and a SD of 0.15. The means ranged in the
Dresden sample from 2.77 (Item 9) to 3.60 (Item 9), with
average M of 3.30 and a SD of 0.25.
For the patient sample the scores revealed a reasonably
normal distribution with the means for skewness and
kurtosis being 0.18 (SD = 0.37) and -0.59 (SD = 0.38),
respectively. None of the items had a skew or a kurtosis
greater than 1 (in absolute value). For the student sample
the scores revealed a reasonably normal distribution with
the means for skewness and kurtosis being -0.51
(SD = 0.16) and -0.34 (SD = 0.18), respectively. None
of the items had a skew or a kurtosis greater than 1
(in absolute value). In the Dresden samples the means for
skewness and kurtosis being -0.87 (SD = 0.35) and 0.64
(SD = 0.64). Items 2, 3, 4 and 8 had a skew and items 3, 4,
8 had a kurtosis greater than 1 (in absolute value).
Study 1: Measurement equivalence of the PMH-scale over
groups
The factorial invariance of the PMH-scale was evaluated
for the following nine groups: students (n = 4674), retest
sample 1 (n = 163), retest sample 2 (n = 973), retest
sample 3 (n = 1237), psychosomatic patients (n = 1440),
stable healthy (n = 675), incidence (n = 303), stable
mentally ill (n = 230), and remission (n = 166). We
analysed the covariance matrices for the nine items
measured at the first occasion. Figure 2 depicts the
factor model that is tested for the nine groups.
The test for configural invariance resulted in a total of
32 misspecifications (out of a total of 324 possible mis-
specifications). We accepted this model without further
modifications (χ2 = 2027.05, df = 243, RMSEA = 0.082,
NNFI = 0.98, 32 misspecifications remaining). Next we
tested the model with the restrictions for metric invari-
ance; that is we added equality constraints across the
groups on the factor loadings of the same items. The
analysis resulted in 35 misspecifications (out of 388
possible misspecifications). We released one of the factor
loading constraints in the group patients. After re-
analysing the data we found 32 misspecifications (out of
388 possible misspecifications). We accepted this model
without additional modifications (χ2 = 2270.09, df = 306,
RMSEA = 0.077, NNFI = 0.98, 32 misspecifications
remaining). Finally, we tested for the scalar invariance
of the PMH-scale, that is we added equality con-
straints across the groups on the item intercepts of
the same items. This resulted in 61 misspecifications
(out of a total of 460 possible misspecifications). We
released eleven item intercepts in nine groups. We
accepted the resulting model without further modifi-
cations (χ2 = 2712.22, df = 358, RMSEA = 0.078, NNFI
= 0.98, 33 misspecifications remaining). In conclusion,
the PMH scale shows configural invariance, partial
metric invariance and partial scalar invariance. Partial
invariance [8] refers to the fact that we had to release
several invariance restrictions during the testing
process. Byrne and colleagues suggest that we can
make valid inferences about relationships between
factors and about the differences between latent fac-
tor means in the model when there are at least two
factor loadings and item intercepts that are con-
strained equal across groups. However, if there is
partial invariance (metric or scalar) then composite
scores should not be used, since they will bias sub-
stantive conclusions [46]. Bias, on the other hand, is
a matter of degree. The more severe the model devi-
ates from full invariance, the larger the potential for
bias. In this study, we found 1 factor loading and 12
item intercepts to be invariant. This is relatively low
to the total number of constraints that still hold, i.e.
149 (80 factor loadings and 70 items intercepts are
still invariant). In the light of these numbers, we do
not think that the degree of invariance will seriously
bias our conclusions. Therefore we will treat the
PMH scale as if it was fully metric and scalar invari-
ant in the subsequent studies.
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Study 2: Measurement equivalence of the PMH-scale
across time
We concluded (study 1) that the partial invariance of the
PMH scale should not seriously threaten the validity of
conclusions resulting from treating the scale as if it was
fully metric and fully scalar invariant. Therefore we will
analyze the pooled data. We do not have a follow-up
measurement for the students; therefore students were
not included in the analysis. The number of observations
for this analysis is 4750 after listwise deletion. We
analysed the covariance matrices for the nine items
measured at the first and second assessment occasion.
The model that we analysed is depicted in Fig. 3. The
model shows two factors that represent the PMH-scale
at the first and second measurement occasion. We intro-
duced correlated errors for the same items across time.
We estimated and tested the model to evaluate the
factorial invariance of the PMH-scale across time. The
analysis resulted in 4 misspecifications (out of 162
possible misspecifications). We accepted this model
Table 3 Means, standard deviations, skewness, kurtosis, factor loadings, item-total score-corrected correlations of the PMH-scale (the
three largest samples)
Item M SD Skewness Kurtosis Factor loading rtt
Patient sample (N = 1547)
1. I am often carefree and in good spirits 2.30 0.84 0.31 -0.43 .78 .71
2. I enjoy my life. 2.32 0.87 0.24 -0.59 .82 .76
3. All in all, I am satisfied with my life. 2.48 0.97 -0.01 -0.99 .72 .64
4. In general, I am confident. 2.78 0.90 -0.30 -0.70 .78 .71
5. I manage well to fulfill my needs. 2.33 0.83 0.21 -0.48 .75 .67
6. I am in good physical and emotional condition. 2.29 0.89 0.17 -0.74 .75 .67
7. I feel that I am actually well equipped to deal with life and its difficulties. 1.62 0.76 1.02 0.31 .63 .55
8. Much of what I do brings me joy. 2.37 0.93 0.08 -0.88 .80 .73
9. I am a calm, balanced human being. 2.75 0.89 -0.13 -0.83 .78 .71
PMH-scale 2.36 0.66 .23 -0.51 - -
Student sample (N = 5406)
1. I am often carefree and in good spirits 2.89 0.84 -0.33 -0.55 .81 .75
2. I enjoy my life. 3.13 0.80 -0.65 -0.06 .84 .78
3. All in all, I am satisfied with my life. 3.12 0.87 -0.70 -0.32 .84 .79
4. In general, I am confident. 3.19 0.80 -0.72 -0.08 .82 .76
5. I manage well to fulfill my needs. 2.81 0.80 -0.30 -0.33 .77 .71
6. I am in good physical and emotional condition. 2.93 0.89 -0.46 -0.57 .82 .76
7. I feel that I am actually well equipped to deal with life and its difficulties. 3.01 0.82 -0.50 -0.34 .82 .76
8. Much of what I do brings me joy. 3.16 0.79 -0.61 -0.32 .81 .75
9. I am a calm, balanced human being. 2.83 0.87 -0.33 -0.58 .64 .57
PMH-scale 3.00 0.66 -0.54 -0.30 - -
Dresden sample (N = 1394)
1. I am often carefree and in good spirits 3.21 0.72 -0.60 0.10 .71 .61
2. I enjoy my life. 3.48 0.65 -1.08 0.83 .71 .61
3. All in all, I am satisfied with my life. 3.45 0.70 -1.20 1.17 .78 .70
4. In general, I am confident. 3.48 0.66 -1.14 1.06 .75 .66
5. I manage well to fulfill my needs. 3.10 0.66 -0.41 0.41 .69 .60
6. I am in good physical and emotional condition. 3.26 0.73 -0.77 0.31 .74 .65
7. I feel that I am actually well equipped to deal with life and its difficulties. 3.31 0.71 -0.84 0.51 .78 .70
8. Much of what I do brings me joy. 3.60 0.60 -1.39 1.64 .74 .65
9. I am a calm, balanced human being. 2.77 0.88 -0.31 -0.61 .52 .43
PMH-scale 3.3 0.50 -0.95 0.94 - -
M mean, SD standard deviations, rtt = Item-Total Score-Corrected Correlations
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(χ2 = 2582.25, df = 125, RMSEA = 0.064, NNFI = 0.97,
4 misspecifications remaining). Next we tested the
model with the restrictions for metric invariance,
that is, we added equality constraints across time on
the factor loadings of the same items. The analysis
resulted in 3 misspecifications (out of 170 possible
misspecifications) and we thus accepted the model
(χ2 = 2599.56, df = 133, RMSEA = 0.062, NNFI = 0.97,
3 misspecifications remaining). Finally, we tested for
scalar invariance of the PMH-scale across time, that
is, we added equality constraints across time on the
item intercepts of the same items. The analysis re-
sulted in 3 misspecifications (out of 179 possible
misspecifications); hence we accepted the model
without further modifications (χ2 = 2458.43, df = 141,
RMSEA = 0.061, NNFI = 0.98, 3 misspecifications
remaining). In conclusion, the PMH-scale is invari-
ant across time and therefore can be used validly
compare PMH-scale scores across time. This is a re-
quirement when sensitivity to change is studied.
Study 3: Test-retest reliability and internal consistency
A change in the score on the PMH-scale should be
the result of actual changes in the level of PMH and
not the result of random measurement error. A high
level of reliability is thus required. We estimated both
the test-retest reliability as well as the internal reli-
ability [44]. The test-retest reliability requires two
measures in a short period of time; so short that one
cannot expect change, but long enough that one can-
not expect recall effect [58]. For the retest samples 1
and 2, the time between the repeated measures was
one week, which is short enough to assess the test-
retest reliability. For retest sample 3, the time interval
was 4 weeks. In addition, we also have retest data
available for other groups in this study and estimated
the across time correlation. In those instances, how-
ever, the time between the repeated measures is not
short enough to assume perfect stability. Therefore
one can expect change across time and in that case
the test-retest correlation indicates (in)stability as well
as reliability. To estimate the test-retest reliability, we
computed a mean score of the nine items of the
PMH-scale at each measurement occasion. The cor-
relation between the mean scores is an estimate of
the reliability.
Test-retest reliability
The Pearson correlation between the first and second
administrations (one week apart) of the PMH-scale in
retest samples 1 and 2 was estimated (Table 4). The test-
retest reliability of the PMH-scale was found to be .81
(p < .01) in retest sample 1 and .77 (p < .001) in retest
sample 2. With a time lag of four weeks (retest sample
3), a test-retest reliability of .74 resulted (p < .001). Thus,
the test-retest reliability is good.
Fig. 2 Path diagram of the measurement model of the PMH-scale
Fig. 3 Path diagram of the two-wave measurement model of the PMH-scale
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Internal consistency
Values for Cronbach’s alpha were estimated for the first
occasion only (Table 4). The estimates were respectively:
.93 for all groups together, .93 for the students, .82 for
retest sample 1, .91 for retest sample 2, .90 for retest
sample 3, .91 for the psychosomatic patients, .84 for the
stable healthy, .87 for the incidence group, .90 for the
stable mentally ill, and.85 for the remission group. The
internal consistency of the PMH-scale was thus high and
similar across different samples.
Across time correlation
The across time correlation between the first and second
administrations of the PMH-scale in the psychosomatic
patients sample and the four groups of the Dresden
sample was estimated (Table 4). The across time correl-
ation of the PMH-scale was found to be .40 (p < .01) in
psychosomatic patients with a time lag of six weeks. The
across time correlation was found to be .57 (p < .01) in
the stable mentally healthy group, .57 (p > .01) in the
incidence group, .66 (p < .01) in the stable mentally ill
group and .57 (p < .01) in the remission group, with a
time lag of 17 months for all four groups.
Study 4: Construct (convergent and discriminant) validity
of the PMH-scale
We assessed the convergent validity of the PMH-scale
with the measures described in the section ‘Instruments’.
The measures EQ-5D, DASS stress, DASS anxiety, DAS
depression, CES-D, SOC negative, N-scale and BDI were
expected to correlate negatively with the PMH-scale and
the measures SWLS, SHS, SOC positive, GKE, LZH and
SOZU-K were expected to correlate positively with the
PMH-scale. We expected no correlations with these
variables age and gender.
Table 5 presents the Pearson correlations between the
PMH-scale and the other measures. All correlations are
quite strong, supporting the construct validity of the
PMH-scale. In addition, the correlations are in the ex-
pected direction, conditional on the positive or negative
coding of the variables. For example satisfaction with life
(SWLS) correlates positively with the PMH-scale (r = .75)
because high scores on the SWLS indicate more satisfac-
tion. Finally, we assessed the discriminant validity using
the variables age and gender. We estimated the correla-
tions between age – PMH-scale and gender – PMH-scale.
As expected, those variables did not significantly correlate
with the PMH-scale. This was not true for the stu-
dents (r = .09; r = .07): In the case of the students,
however, the sample size (n = 4667) is so large that
even small correlations become significant.
Study 5: Sensitivity to (therapeutic) change
The PMH-scale should be able to detect changes in
PMH across time. We already established (study 2) that
the PMH-scale is scalar invariant across time, which is
necessary for unbiased comparisons across time. Trad-
itionally change across time is assessed with a paired
samples t-test. We will use the 4 groups in the Dresden
sample and the sample of psychosomatic patients to
study sensitivity to therapeutic change. The psycho-
somatic patients administered the PMH-scale twice with
an interval of six weeks while receiving behaviorally
oriented inpatient therapy. In the Dresden sample all
participants completed the PMH scale twice within an
interval of approximately 17 months. At both adminis-
trations the participants were classified with a structured
clinical interview for DSM-IV diagnoses. Participants,
who were diagnosed with a disorder, only very rarely
searched for treatment.
Table 4 Test retest reliability, internal consistency and across time correlation of the PMH-scale
Samples Test-retest reliability Internal consistency Across time correlation
na r α r
Students 4674 - .93 -
Retest sample 1 138 .81** .82 -
Retest sample 2 941 .77** .91 -
Retest sample 3 1194 .74** .90 -
Psychosomatic patients 1440 - .91 .40**
Dresden sample – stable mentally healthy 683 - .84 .57**
Dresden sample – incidence 166 - .87 .57
Dresden sample – stable mentally ill 232 - .90 .66**
Dresden sample – remission 310 - .85 .57**
All groups 7652 - .93 -
an is the maximum number of participants in the analyses. The number of participants varied for each analysis
**p < .01
Lukat et al. BMC Psychology  (2016) 4:8 Page 10 of 14
Table 6 shows that PMH improved for all groups,
however, the improvement for the groups in the Dresden
sample is very modest, to say the least. The psycho-
somatic patients improved their PMH significantly,
t(1230) = 17.51, p = .00, after 6 weeks of treatment. The
effect size is moderate (Cohen’s d = .50). The improve-
ment in PMH of the psychosomatic patients is corrobo-
rated by a simultaneous change in global health. Global
health was measured with the GAF scale. There was a
significant change in the GAF score between the first
and second administration, t(561) = 24.40, p = .00). The
effect size was large (Cohen’s d = .80).
The stable healthy improve significantly, t(682) = 4.92,
p = .00, with a small effect size (Cohen’s d = .19). The
stable mentally ill improve significantly, t(231) = 2.47,
p = .01, with a small effect size (Cohen’s d = .16). The
incidence group does not improve significantly,
t(168) = 0.56, p = .58, with a small effect size (Cohen’s d
= .04). Finally remission group also improves significantly,
t(309) = 3.54, p = .00, with a small effect size (Cohen’s
d = .22). These results are counterintuitive at first
glance, one would expect a decrease in PMH for the
incidence group, an increase in PMH for the remis-
sion group, and no change for the other two groups. How-
ever, all groups, except for the incidence group, improve
significantly but the effect sizes are very small. At second
glance, the Dresden sample is a non-clinical sample and
only few expressed a wish for professional help [6]. Of the
1394 participants, 61 (4.4 %) women received psycho-
therapeutic treatment at baseline and 75 (5.4 %) at follow-
up. On possible explanation is that the participants did
not consider their overall well-being to be very strongly
impaired. Therefore these findings are not so surprising
after all.
The previous analyses illustrated that the PMH scale is
sensitive to change at the aggregate level. This analysis
does, however, ignore the effect of the unreliability of
the test. If measurement error is present in the test
Table 5 Pearson correlations of the PMH-scale with other scales at baseline
Scales PMH-scale
Students Retest sample 1 Retest sample 2 Retest sample 3 Patients Stable healthy Incidence Stable mentally ill Remission
SWLS .75* - - - - - - - -
EQ-5D -.59* - - - - - - - -
SHS .81* - - - - - - - -
DASS stress -.56* - - - - - - - -
DASS anxiety -.51* - - - - - - - -
DASS depression -.74* - - - - - - - -
CES-D - -.57* - - -.71* - - - -
SOC positive - .26* - - .59* - - - -
SOC negative - -.44* - - -.61* - - - -
N-scale - -.50* - - -.65* -.53* -.56* -.64* -.58*
BDI - - - - - -.53* -.48* -.68* -.64*
GKE - - - - - .52* .53* .65* .52*
LZH - - - - - .48* .59* .58* .58*
SOZU-K .52* - - - - .49* .52* .57* .52*
Age -.09* .00 .09* .05 .04 .04 .06 .04 -.07
Gender .07* .10 .09* -.01 -.04 - - - -
* p < .05
Table 6 Change across time of the PMH-scale
n Mt1 (SD) Mt2 (SD) Mt2-Mt1 SEMt2-Mt1
Psychosomatic patients 1231 2.35 (.66) 2.62 (.69) .27** .015
Dresden sample – stable mentally healthy 683 3.42 (.42) 3.49 (.39) .07** .014
Dresden sample – incidence 169 3.27 (.48) 3.29 (.50) .02 .035
Dresden sample – stable mentally ill 232 2.97 (.60) 3.05 (.62) .08* .033
Dresden sample – remission 310 3.28 (.46) 3.37 (.42) .08** .023
M mean, SD standard deviations, SE standard error
* p < .05, **p < .01
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score, then any observed change is an overestimate of
the true change. In a clinical setting individual change is
an important process parameter. In order to assess
whether an individual’s change exceeds a change that
can be expected due to the unreliability of the test, we
use the Reliable Change Index (RCI). The reliable
change index [25] can be considered a lower limit for
clinical significant change. The RCI transforms the
observed change into a standardized change score,
taking measurement error into account. If this standard-
ized change score exceeds 1.96 then there is a clinically
significant change (p < .05). The RCI is computed from
the test-retest reliability (rTR = .81) and the standard
deviation (SDt1 = 0.64) of the PMH score at the first
administration. In total 211 (17.1 %) out of the 1231
psychosomatic patients showed a clinically significant
change. This low number is not an indication that the
PMH is not a valid instrument. To be specific, Jacobson
et al. [26] warned against the misuse of the RCI to valid-
ate new measures “the method is not intended for validat-
ing the sensitivity of outcome measures.” In conclusion,
17.1 % merely indicates the percentage of patients that
improved beyond the unreliability of the PMH scale. This
is not a large percentage; however, psychosomatic disor-
ders are among the most frustrating mental disorders for
clinicians to manage and also result in high levels of
patient dissatisfaction (e.g. [24]).
Discussion
The PMH-scale was originally developed by Lutz et al.
(1992a, unpublished manuscript) in order to provide a
brief, unidimensional and person-centred instrument to
assess positive mental health. In the present series of stud-
ies the PMH-scale was confirmed to be a unidimensional
self-report instrument with high internal consistency,
good retest-reliability, scalar invariance across samples
and over time, good convergent and discriminant validity
as well as sensitivity to therapeutic change in a series
samples from very different backgrounds. The unidimen-
sional structure of the PMH-scale suggests that it indeed
measures a single concept. The equivalence tests indicate
that the PMH-scale can be validly used to compare PMH-
scale scores over groups and across time. The good test-
retest reliability for the retest samples and the moderate
correlation between the first and second measure for the
psychosomatic patient group and Dresden sample sug-
gests that the PMH-scale is both: stable over time and
sensitive to change. With only nine items, the PMH-scale
is brief and easy to interpret.
The present findings should be interpreted in light of
the strengths and limitations of data collection. Particu-
lar strengths are that our study is based on several large,
diverse samples from various areas of life, the prospect-
ive design in a community-based sample (Dresden
sample) and the examination of validity of the PMH-
scale with a broad range of questionnaires. Several limi-
tations should also be noted. The fact that the partici-
pants for the first retest sample were recruited from the
surroundings of the first author due to data availability,
may have given rise to sample selection bias [20]. Inter-
estingly, the results of the two other, very large represen-
tative samples used for assessing retest reliability were
not much lower. Because the patient sample consisted of
psychosomatic patients, the results on therapeutic
change cannot be generalized to other mental health
outpatients. In addition, for addressing the scale’s sensi-
tivity to change (study 5) we do not have a comparison
condition (such as a waitlist-control group, or a placebo
control group). Furthermore, the data was collected
twelve years ago. This means, that the diagnoses were
based on the criteria of ICD-9, an older diagnostic tool
for health assessment. Further studies should include
more patient samples with a clear diagnosis based on
more current diagnostic tools. The Dresden sample con-
sisted of well-educated young women with a predomin-
ately medium to high socioeconomic status, which of
course is not necessarily true for other populations.
Nevertheless, the fact that the PMH-scale proved to be
an important predictor for remission of phobias as
assessed by state-of-the-art DSM-IV diagnoses is an
argument for its potential usefulness in epidemiologic
and clinical research. It may be beneficial for mental
health care to focus on psychopathology and its treat-
ment but also on promotion of positive mental health.
Examples of mental health promotion in health care are
well-being therapy [13] and Acceptance and Commit-
ment Therapy [19], both psychotherapeutic approaches
for increasing well-being. The PMH-scale can be used
to examine the improvements in mental health. Pa-
tients may complete the PMH-scale at baseline and at
regular intervals or the end of an outpatient or
inpatient treatment.
Conclusions
The PMH-scale is a good instrument for assessment
of PMH in community and mental-health care. The
PMH-scale provides a quick overall assessment of
PMH. Because of its scalar invariance across time and
its sensitivity to change, the PMH-scale may also be
used for determining the effect of therapeutic or
medical treatment on PMH.
Endnotes
1Mental health is a much contested area and there is
no general agreement on terminology. For consistency,
we will use the terms positive mental health (PMH) and
mental disorder/mentally ill throughout this article.
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2More detailed information about reliability in the
respective samples and the validity of the instruments
can be obtained on request.
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